Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients.

by Nicholas Funderburg, Magdalena Kalinowska, James Eason, James Goodrich, Jayvant Heera, Howard Mayer, Natasa Rajicic, Hernan Valdez, Michael M Lederman
Published 2010-10-01

The ixCELL-DCM Trial: Rationale and Design

by Timothy D. Henry M.D., Gary L. Schaer, Anthony Demaria, David Recker, Ann E. Remmers, James Goodrich, Amit N. Patel
Published 2016-09-01